ZEBRA: an ACCRU/IRCI multicenter phase 2 study of pembrolizumab in patients with advanced small bowel adenocarcinoma (SBA)

K. Pedersen, N. Foster, M. Overman, P. Boland, S. Kim, K. Arrambide, B. Jaszewski, J. Welch, R. Wilson, R. McWilliams

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)iv128
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
StatePublished - Jul 1 2019

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this